Similar articles

• NAD(P)H-quinone oxidoreductase 1 silencing aggravates hormone-induced prostatic hyperplasia in mice.

  Kim HT, Kim YJ, Park SR, Ryu SY, Jung JY. Kim HT, et al. Andrologia. 2018 Apr;50(3). doi: 10.1111/and.12906. Epub 2017 Nov 6. Andrologia. 2018. PMID: 29110315
• Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.

  Jaiswal AK, Burnett P, Adesnik M, McBride OW. Jaiswal AK, et al. Biochemistry. 1990 Feb 20;29(7):1899-906. doi: 10.1021/bi00459a034. Biochemistry. 1990. PMID: 1691923
• NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.

  Jamieson D, Wilson K, Pridgeon S, Margetts JP, Edmondson RJ, Leung HY, Knox R, Boddy AV. Jamieson D, et al. Clin Cancer Res. 2007 Mar 1;13(5):1584-90. doi: 10.1158/1078-0432.CCR-06-1416. Clin Cancer Res. 2007. PMID: 17332305
• Quinone oxidoreductases in protection against myelogenous hyperplasia and benzene toxicity.

  Iskander K, Jaiswal AK. Iskander K, et al. Chem Biol Interact. 2005 May 30;153-154:147-57. doi: 10.1016/j.cbi.2005.03.019. Epub 2005 Apr 7. Chem Biol Interact. 2005. PMID: 15935811 Review.
• NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms.

  Ross D, Kepa JK, Winski SL, Beall HD, Anwar A, Siegel D. Ross D, et al. Chem Biol Interact. 2000 Dec 1;129(1-2):77-97. doi: 10.1016/s0009-2797(00)00199-x. Chem Biol Interact. 2000. PMID: 11154736 Review.